glp-1 news employers Employer FAQs on the Rise of Drugs for Weight Loss and the Workplace Impact Perspectives from Employers on the

Clinical effectiveness of currently used antidepressant drugs, which target monoaminergic systems in the brain mainly by enhancing serotoninergic and noradrenergic neurotransmission, is very often low and insufficient since approximately only one-third of the patients achieve complete remission of depressive symptoms after therapy

Sinee Weschawalit, Siriwan Thongthip, Phanupong Phutrakool, and Pravit Asawanonda - Glutathione and its antiaging and antimelanogenic effects - Clin Cosmet Investig Dermatol - 2017

Novo Nordisk officials said the price cuts are aimed at making the drug more affordable for consumers with insurance plans that link coverage to the medications' list price

This pipeline indicates that the performance ceiling for peptide-based obesity therapeutics has not yet been reached, sustaining investor and commercial expectations well into the 2030s